Publication not explained

This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.

If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.

Featured Image

Read the Original

This page is a summary of: Evolving treatment strategies in CML - moving from early and deep molecular responses to TKI discontinuation and treatment-free remission: is there a need for longer-term trial outcomes?, British Journal of Clinical Pharmacology, June 2018, Wiley,
DOI: 10.1111/bcp.13637.
You can read the full text:

Read

Contributors

The following have contributed to this page